VeriMomsh-tetrapeptide-38 trifluoroacetate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
Related ingredients
Frequently asked questions
- sh-tetrapeptide-38 trifluoroacetate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
- sh-tetrapeptide-38 trifluoroacetate est-il sûr pendant l'allaitement ?
- No data found indicating systemic exposure, transfer into breastmilk, or lactation toxicity. Given the lack of reproductive or developmental hazard data and expected low dermal absorption of short peptides, exposure via breastmilk is considered negligible for topical cosmetic use (sources searched: SCCS/CIR, PubMed, PubChem, CosIng, ECHA).
- sh-tetrapeptide-38 trifluoroacetate est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or toxicity data found. Mechanistic/toxic effects not identified. Exposure rating increased by +1 for baby skin relative to adults because infants have an immature skin barrier and higher surface‑area‑to‑weight ratio; although adult dermal absorption is considered negligible, infant exposure is plausibly low but measurable for topical application. No evidence found of specific hazard to infants aged 0–3 years (sources searched: PubMed, CosIng, ECHA, PubChem, EWG).
- Comment VeriMom évalue-t-il sh-tetrapeptide-38 trifluoroacetate ?
- VeriMom évalue sh-tetrapeptide-38 trifluoroacetate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sh-tetrapeptide-38 trifluoroacetate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sh-tetrapeptide-38 trifluoroacetate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.